Citadel Advisors’s Cellectar Biosciences CLRB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-343,258
| Closed | -$108K | – | 5958 |
|
2025
Q1 | $108K | Buy |
+343,258
| New | +$108K | ﹤0.01% | 5125 |
|
2024
Q4 | – | Sell |
-303
| Closed | -$648 | – | 6076 |
|
2024
Q3 | $648 | Sell |
303
-49,924
| -99% | -$107K | ﹤0.01% | 5645 |
|
2024
Q2 | $126K | Sell |
50,227
-67,462
| -57% | -$169K | ﹤0.01% | 4863 |
|
2024
Q1 | $468K | Buy |
117,689
+48,682
| +71% | +$194K | ﹤0.01% | 3985 |
|
2023
Q4 | $191K | Buy |
+69,007
| New | +$191K | ﹤0.01% | 4628 |
|
2023
Q3 | – | Sell |
-30,790
| Closed | -$60K | – | 5934 |
|
2023
Q2 | $60K | Buy |
+30,790
| New | +$60K | ﹤0.01% | 4933 |
|
2023
Q1 | – | Sell |
-18,670
| Closed | -$31.9K | – | 5989 |
|
2022
Q4 | $31.9K | Buy |
+18,670
| New | +$31.9K | ﹤0.01% | 5418 |
|
2022
Q3 | – | Sell |
-68,990
| Closed | -$28K | – | 5966 |
|
2022
Q2 | $28K | Buy |
+68,990
| New | +$28K | ﹤0.01% | 5648 |
|
2022
Q1 | – | Sell |
-164,576
| Closed | -$109K | – | 6427 |
|
2021
Q4 | $109K | Buy |
+164,576
| New | +$109K | ﹤0.01% | 5855 |
|
2021
Q1 | – | Sell |
-34,200
| Closed | -$71K | – | 6309 |
|
2020
Q4 | $71K | Buy |
+34,200
| New | +$71K | ﹤0.01% | 4778 |
|
2020
Q2 | – | Sell |
-12,155
| Closed | -$15K | – | 4698 |
|
2020
Q1 | $15K | Buy |
+12,155
| New | +$15K | ﹤0.01% | 4695 |
|
2019
Q2 | – | Sell |
-17,760
| Closed | -$42K | – | 4681 |
|
2019
Q1 | $42K | Buy |
17,760
+3,166
| +22% | +$7.49K | ﹤0.01% | 4273 |
|
2018
Q4 | $23K | Buy |
+14,594
| New | +$23K | ﹤0.01% | 4229 |
|
2018
Q3 | – | Sell |
-56,299
| Closed | -$35K | – | 4331 |
|
2018
Q2 | $35K | Buy |
+56,299
| New | +$35K | ﹤0.01% | 3956 |
|
2018
Q1 | – | Sell |
-14,215
| Closed | -$19K | – | 4014 |
|
2017
Q4 | $19K | Buy |
+14,215
| New | +$19K | ﹤0.01% | 3772 |
|
2017
Q2 | – | Sell |
-18,990
| Closed | -$43K | – | 3705 |
|
2017
Q1 | $43K | Buy |
+18,990
| New | +$43K | ﹤0.01% | 3423 |
|